BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 9188221)

  • 1. Multi-center sestamibi parathyroid imaging study in Hawaii.
    Cheung AH; Wheeler MS; Madanay LD; Hew E; Coel MN; Wong LM
    Hawaii Med J; 1997 May; 56(5):114-7, 120. PubMed ID: 9188221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual-phase 99mTc-sestamibi imaging: its utility in parathyroid hyperplasia and use of immediate/delayed image ratios to improve diagnosis of hyperparathyroidism.
    Gordon L; Burkhalter W; Mah E
    J Nucl Med Technol; 2002 Dec; 30(4):179-84. PubMed ID: 12446751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective comparison of dual-phase technetium-99m-sestamibi scintigraphy and high resolution ultrasonography in the evaluation of abnormal parathyroid glands.
    Light VL; McHenry CR; Jarjoura D; Sodee DB; Miron SD
    Am Surg; 1996 Jul; 62(7):562-7; discussion 567-8. PubMed ID: 8651552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study).
    Taillefer R; Boucher Y; Potvin C; Lambert R
    J Nucl Med; 1992 Oct; 33(10):1801-7. PubMed ID: 1328564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [99mTc-MIBI scintigraphy for the detection of parathyroid lesions in patients with hyperparathyroidism].
    Okuda I; Saitoh K; Maruno T; Hatano O; Takizawa Y; Murata H; Koyano H; Ozawa Y; Shimizu T; Shishiba Y
    Kaku Igaku; 1995 Jun; 32(6):557-62. PubMed ID: 7674565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usefulness of 99mTc-methoxy-isobutyl-isonitrile scintigraphy for preoperative localization of adenoma in primary hyperparathyroidism].
    Yamaguchi S; Kobayashi Y; Tsujikawa K; Noma M; Mori N; Hara T; Takao T; Takada S; Sugao H; Yoshida S
    Hinyokika Kiyo; 2001 Sep; 47(9):619-23. PubMed ID: 11692597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
    Billy HT; Rimkus DR; Hartzman S; Latimer RG
    Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technetium99m-sestamibi scanning before initial neck exploration in patients with primary hyperparathyroidism.
    Bugis SP; Berno E; Rusnak CH; Chu D
    Eur Arch Otorhinolaryngol; 1995; 252(3):149-52. PubMed ID: 7662349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m-methoxyisobutylisonitrile in localization of ectopic parathyroid adenoma.
    Bernà L; Caixàs A; Piera J; Gómez G; Matías-Guiu X; Estorch M; Puig M; Carrió I
    J Nucl Med; 1996 Apr; 37(4):631-3. PubMed ID: 8691254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfunctional parathyroid glands with 99mTc-MIBI scan: semiquantitative analysis correlated with histologic findings.
    Takebayashi S; Hidai H; Chiba T; Takagi Y; Nagatani Y; Matsubara S
    J Nucl Med; 1999 Nov; 40(11):1792-7. PubMed ID: 10565772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parathyroid imaging with technetium-99m-sestamibi: preoperative localization and tissue uptake studies.
    O'Doherty MJ; Kettle AG; Wells P; Collins RE; Coakley AJ
    J Nucl Med; 1992 Mar; 33(3):313-8. PubMed ID: 1531500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
    Nguyen BD
    Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.
    Lee VS; Wilkinson RH; Leight GS; Coogan AC; Coleman RE
    Radiology; 1995 Dec; 197(3):627-33. PubMed ID: 7480730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parathyroid scintigraphy with iodine-123 and 99mTc-sestamibi: imaging findings.
    Burke GJ; Wei JP; Binet EF
    AJR Am J Roentgenol; 1993 Dec; 161(6):1265-8. PubMed ID: 8249740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content.
    Carpentier A; Jeannotte S; Verreault J; Lefebvre B; Bisson G; Mongeau CJ; Maheux P
    J Nucl Med; 1998 Aug; 39(8):1441-4. PubMed ID: 9708524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99Tcm sestamibi--a new agent for parathyroid imaging.
    Coakley AJ; Kettle AG; Wells CP; O'Doherty MJ; Collins RE
    Nucl Med Commun; 1989 Nov; 10(11):791-4. PubMed ID: 2532313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures.
    Billotey C; Aurengo A; Najean Y; Sarfati E; Moretti JL; Toubert ME; Rain JD
    J Nucl Med; 1994 Oct; 35(10):1631-6. PubMed ID: 7931661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary results of thallium 201 and technetium 99m subtraction scanning of parathyroid glands.
    Wheeler MH; Harrison BJ; French AP; Leach KG
    Surgery; 1984 Dec; 96(6):1078-82. PubMed ID: 6095480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.